Cargando…

Change of Title: From High-Throughput to BioTech

Detalles Bibliográficos
Autores principales: Iadarola, Paolo, Negrini, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258314/
https://www.ncbi.nlm.nih.gov/pubmed/35822821
http://dx.doi.org/10.3390/biotech9040018
_version_ 1784741522677170176
author Iadarola, Paolo
Negrini, Massimo
author_facet Iadarola, Paolo
Negrini, Massimo
author_sort Iadarola, Paolo
collection PubMed
description
format Online
Article
Text
id pubmed-9258314
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92583142022-07-06 Change of Title: From High-Throughput to BioTech Iadarola, Paolo Negrini, Massimo BioTech (Basel) Editorial MDPI 2020-09-22 /pmc/articles/PMC9258314/ /pubmed/35822821 http://dx.doi.org/10.3390/biotech9040018 Text en © 2020 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Editorial
Iadarola, Paolo
Negrini, Massimo
Change of Title: From High-Throughput to BioTech
title Change of Title: From High-Throughput to BioTech
title_full Change of Title: From High-Throughput to BioTech
title_fullStr Change of Title: From High-Throughput to BioTech
title_full_unstemmed Change of Title: From High-Throughput to BioTech
title_short Change of Title: From High-Throughput to BioTech
title_sort change of title: from high-throughput to biotech
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258314/
https://www.ncbi.nlm.nih.gov/pubmed/35822821
http://dx.doi.org/10.3390/biotech9040018
work_keys_str_mv AT iadarolapaolo changeoftitlefromhighthroughputtobiotech
AT negrinimassimo changeoftitlefromhighthroughputtobiotech